The risk of aprotinin: a conflict of evidence.
Sedrakyan
Artyom
A
Agency for Healthcare Research and Quality, Rockville, Maryland, USA.
Atkins
David
D
Treasure
Tom
T
D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D019106:Postoperative Hemorrhage / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic
D006490:Hemostatics; D007611:Aprotinin